Post by account_disabled on Feb 27, 2024 6:24:19 GMT -5
A medical journal has retracted two studies that claimed to show harm from the abortion pill mifepristone, citing conflicts of interest on the part of the authors and flaws in their research. Two of the three studies retracted by medical publisher Sage Perspectives were cited in a seminal Texas court ruling that threatened access to the pill. The U.S. Supreme Court will take up the case next month and a decision is expected later this year. The court ruling could affect access to mifepristone nationwide, even if it continues to be available by mail. Medication abortion accounts for more than half of all abortions in the U.S. and typically involves two medications: mifepristone and misoprostol. Here's what you should know about retractions Both studies cited in the court ruling were published in the journal Health Services Research and Managerial Epidemiology. They were supported by the Charlotte Lozier Institute, part of an advocacy group seeking to end access to abortion. A 2021 paper analyzed abortions and more than 121,000 emergency room visits after medication abortions and abortions performed through a medical procedure between .
The researchers concluded that medication abortions are "consistently and progressively associated with greater morbidity from post-abortion emergency visits” than the other type. . A 2022 article concluded that failure to identify a prior abortion during an emergency room visit (either by a doctor or because a patient concealed it) is “a significant risk Paraguay WhatsApp Number factor for subsequent hospital admission.” District Judge Matthew Kacsmaryk cited the studies in a controversial legal ruling that will be presented to the U.S. Supreme Court next month. Essentially, Kacsmaryk sided with a conservative Christian medical group, arguing that the original approval of mifepristone by U.S. regulators was flawed because it overlooked serious safety issues with the pill. He cited one of the retracted studies as saying that mifepristone causes "many intense side effects." The ruling also cited the second retracted document in explaining why anti-abortion doctors had the legal standing to bring their lawsuithe judge said medical abortions cause “enormous pressure and stress” on doctors.
Many legal experts and medical professionals were deeply skeptical of the arguments and statistics cited in Kacsmaryk's decision, and a federal appeals court overturned parts of the ruling last summer. The Food and Drug Administration's original approval of mifepristone in 2000 is not in question, but the Supreme Court could reverse recent changes that made the drug easier to obtain, including through mail order. WHY WERE THE STUDIES WITHDRAWN? In a retraction notice, Sage Perspectives said a reader contacted the journal with concerns about the presentation of some of the data, possible "flaws" in the selection of the data, and whether the authors' affiliations with anti-abortion advocacy organizations They present conflicts of interest that should have been disclosed. Sage said in a statement that it asked two experts to conduct an independent post-publication peer review, which found that the conclusions "were invalidated in whole or in part" for several reasons, including problems with the study design and methodology and errors. In the analysis. of the data. The studies' lead author, James Studnicki, said in an emailed statement that the publisher's actions are a "baseless attack on our scientific research and studies.
The researchers concluded that medication abortions are "consistently and progressively associated with greater morbidity from post-abortion emergency visits” than the other type. . A 2022 article concluded that failure to identify a prior abortion during an emergency room visit (either by a doctor or because a patient concealed it) is “a significant risk Paraguay WhatsApp Number factor for subsequent hospital admission.” District Judge Matthew Kacsmaryk cited the studies in a controversial legal ruling that will be presented to the U.S. Supreme Court next month. Essentially, Kacsmaryk sided with a conservative Christian medical group, arguing that the original approval of mifepristone by U.S. regulators was flawed because it overlooked serious safety issues with the pill. He cited one of the retracted studies as saying that mifepristone causes "many intense side effects." The ruling also cited the second retracted document in explaining why anti-abortion doctors had the legal standing to bring their lawsuithe judge said medical abortions cause “enormous pressure and stress” on doctors.
Many legal experts and medical professionals were deeply skeptical of the arguments and statistics cited in Kacsmaryk's decision, and a federal appeals court overturned parts of the ruling last summer. The Food and Drug Administration's original approval of mifepristone in 2000 is not in question, but the Supreme Court could reverse recent changes that made the drug easier to obtain, including through mail order. WHY WERE THE STUDIES WITHDRAWN? In a retraction notice, Sage Perspectives said a reader contacted the journal with concerns about the presentation of some of the data, possible "flaws" in the selection of the data, and whether the authors' affiliations with anti-abortion advocacy organizations They present conflicts of interest that should have been disclosed. Sage said in a statement that it asked two experts to conduct an independent post-publication peer review, which found that the conclusions "were invalidated in whole or in part" for several reasons, including problems with the study design and methodology and errors. In the analysis. of the data. The studies' lead author, James Studnicki, said in an emailed statement that the publisher's actions are a "baseless attack on our scientific research and studies.